Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rebus Biosystems is a life science technology company focused on providing high-resolution spatial omics solutions. The company's flagship product, the Rebus Esper spatial omics platform, integrates automated fluidics, image processing, and chemistry to enable high-throughput, single-molecule detection of RNA and proteins within their original tissue context. By combining Synthetic Aperture Optics (SAO) with advanced microfluidics, Rebus Biosystems allows researchers to map cellular landscapes with subcellular resolution across large tissue areas. Their technology is primarily utilized in neuroscience, oncology, and infectious disease research to understand the spatial organization of biological systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rebus Holdings.